Faron Pharmaceuticals Oy Management
Management criteria checks 2/4
Faron Pharmaceuticals Oy's CEO is Markku Jalkanen, appointed in Jan 2006, has a tenure of 18.33 years. total yearly compensation is €511.73K, comprised of 77.8% salary and 22.2% bonuses, including company stock and options. directly owns 4.6% of the company’s shares, worth £4.97M. The average tenure of the management team and the board of directors is 1.9 years and 4.7 years respectively.
Key information
Markku Jalkanen
Chief executive officer
€511.7k
Total compensation
| CEO salary percentage | 77.8% |
| CEO tenure | 18.3yrs |
| CEO ownership | 4.6% |
| Management average tenure | 1.9yrs |
| Board average tenure | 4.7yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | €512k | €398k | -€31m |
| Sep 30 2023 | n/a | n/a | -€30m |
| Jun 30 2023 | n/a | n/a | -€29m |
| Mar 31 2023 | n/a | n/a | -€29m |
| Dec 31 2022 | €635k | €539k | -€29m |
Compensation vs Market: Markku's total compensation ($USD547.13K) is above average for companies of similar size in the UK market ($USD344.28K).
Compensation vs Earnings: Markku's compensation has been consistent with company performance over the past year.
CEO
Markku Jalkanen (69 yo)
18.3yrs
Tenure
€511,731
Compensation
Dr. Markku Tapani Jalkanen, Ph.D. serves as a Partner and Advisor at Inveni Capital. Dr. Jalkanen founded Faron Pharmaceuticals Oy in 2006 and has been its Chief Executive Officer since 2007 and served as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 18.3yrs | €511.73k | 4.6% € 4.8m | |
| Chief Operating Officer | 2.3yrs | €511.73k | no data | |
| Interim Chief Financial Officer | less than a year | €455.09k | no data | |
| Chief Scientific Officer | 1.4yrs | no data | no data | |
| General Counsel | no data | no data | no data | |
| Head of Communications | no data | no data | no data | |
| Chief Commercial Officer | 6.3yrs | no data | no data | |
| Interim Chief Medical Officer | less than a year | no data | no data |
1.9yrs
Average Tenure
58yo
Average Age
Experienced Management: FARN's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 17.6yrs | €511.73k | 4.6% € 4.8m | |
| Chairman of the Scientific Advisory Board | 5.7yrs | €33.69k | no data | |
| Board Observer | 5.7yrs | €36.20k | no data | |
| Independent Non-Executive Director | 7yrs | €42.00k | 0.014% € 14.5k | |
| Member of the Scientific Advisory Board | 4.7yrs | no data | no data | |
| Independent Non-Executive Chairman | 1.2yrs | €20.97k | 0.016% € 17.1k | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Member of the Scientific Advisory Board | 4.7yrs | no data | no data | |
| Member of the Scientific Advisory Board | 4.7yrs | no data | no data | |
| Member of the Scientific Advisory Board | 3.3yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
4.7yrs
Average Tenure
65yo
Average Age
Experienced Board: FARN's board of directors are considered experienced (4.7 years average tenure).